Correlation Between Spero Therapeutics and Applied Therapeutics

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Spero Therapeutics and Applied Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Spero Therapeutics and Applied Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Spero Therapeutics and Applied Therapeutics, you can compare the effects of market volatilities on Spero Therapeutics and Applied Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Spero Therapeutics with a short position of Applied Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Spero Therapeutics and Applied Therapeutics.

Diversification Opportunities for Spero Therapeutics and Applied Therapeutics

-0.6
  Correlation Coefficient

Excellent diversification

The 3 months correlation between Spero and Applied is -0.6. Overlapping area represents the amount of risk that can be diversified away by holding Spero Therapeutics and Applied Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Applied Therapeutics and Spero Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Spero Therapeutics are associated (or correlated) with Applied Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Applied Therapeutics has no effect on the direction of Spero Therapeutics i.e., Spero Therapeutics and Applied Therapeutics go up and down completely randomly.

Pair Corralation between Spero Therapeutics and Applied Therapeutics

Given the investment horizon of 90 days Spero Therapeutics is expected to under-perform the Applied Therapeutics. But the stock apears to be less risky and, when comparing its historical volatility, Spero Therapeutics is 2.79 times less risky than Applied Therapeutics. The stock trades about -0.02 of its potential returns per unit of risk. The Applied Therapeutics is currently generating about 0.09 of returns per unit of risk over similar time horizon. If you would invest  335.00  in Applied Therapeutics on August 25, 2024 and sell it today you would earn a total of  628.00  from holding Applied Therapeutics or generate 187.46% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthWeak
Accuracy100.0%
ValuesDaily Returns

Spero Therapeutics  vs.  Applied Therapeutics

 Performance 
       Timeline  
Spero Therapeutics 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Spero Therapeutics has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of weak performance in the last few months, the Stock's basic indicators remain very healthy which may send shares a bit higher in December 2024. The recent disarray may also be a sign of long period up-swing for the firm investors.
Applied Therapeutics 

Risk-Adjusted Performance

9 of 100

 
Weak
 
Strong
OK
Compared to the overall equity markets, risk-adjusted returns on investments in Applied Therapeutics are ranked lower than 9 (%) of all global equities and portfolios over the last 90 days. In spite of comparatively weak essential indicators, Applied Therapeutics unveiled solid returns over the last few months and may actually be approaching a breakup point.

Spero Therapeutics and Applied Therapeutics Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Spero Therapeutics and Applied Therapeutics

The main advantage of trading using opposite Spero Therapeutics and Applied Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Spero Therapeutics position performs unexpectedly, Applied Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Applied Therapeutics will offset losses from the drop in Applied Therapeutics' long position.
The idea behind Spero Therapeutics and Applied Therapeutics pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Comparator module to compare the composition, asset allocations and performance of any two portfolios in your account.

Other Complementary Tools

Positions Ratings
Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance
Price Ceiling Movement
Calculate and plot Price Ceiling Movement for different equity instruments
Competition Analyzer
Analyze and compare many basic indicators for a group of related or unrelated entities
Stock Tickers
Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites
Equity Search
Search for actively traded equities including funds and ETFs from over 30 global markets